This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read ZIVO Bioscience’s 8K filing here.
About ZIVO Bioscience
ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.
Read More
- Five stocks we like better than ZIVO Bioscience
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Sizing Up a New Opportunity for NVIDIA Investors
- Election Stocks: How Elections Affect the Stock Market
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- The 3 Biggest M&A Stock Opportunities for 2025
